James B. Meigs, M.D., M.P.H. (MGH/Broad, General Internal Medicine) focuses on the cause and prevention of type 2 diabetes and cardiovascular disease using biochemical and genetic epidemiology and health services translational research. He leads the diabetes genetics research at the Framingham Heart Study and is a senior member of several large international genomics consortia, including MAGIC, DIAGRAM, AAGILE, CHARGE-diabetes, and TOPMed diabetes.